Pradaxa
Product Images NDC 21695-899

4 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pradaxa (NDC 21695-899). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Praxada (dabigatran Etexilate Mesylate) Structure (5db7f199 8752 4d24 85f7 E34ca8f4d02e 01)

Praxada (dabigatran Etexilate Mesylate) Structure (5db7f199 8752 4d24 85f7 E34ca8f4d02e 01)
Chemical structure of the active ingredient in PRADAXA, showing a detailed molecular formula with various functional groups and atoms, including aromatic rings, nitrogen, oxygen, and sulfur components.*
FDA Label Image

Kaplan-meier Curve Estimate Of Time To First Stroke Or Systemic Embolism (5db7f199 8752 4d24 85f7 E34ca8f4d02e 02)

Kaplan-meier Curve Estimate Of Time To First Stroke Or Systemic Embolism (5db7f199 8752 4d24 85f7 E34ca8f4d02e 02)
A Kaplan-Meier probability plot comparing Warfarin and PRADAXA (Dabigatran) doses 110 mg bid and 150 mg bid over time in months. The x-axis represents time from randomization in months, and the y-axis represents event probability. The graph includes patient count at risk for each group over the study period.*
FDA Label Image

Stroke And Systemic Embolism Hazard Ratios By Baseline Characteristics (5db7f199 8752 4d24 85f7 E34ca8f4d02e 03)

Stroke And Systemic Embolism Hazard Ratios By Baseline Characteristics (5db7f199 8752 4d24 85f7 E34ca8f4d02e 03)
A forest plot comparing PRADAXA 150 and Warfarin across various patient subgroups, including age, gender, BMI, renal function, and comorbidities. The plot shows hazard ratios with 95% confidence intervals and p-values for interaction assessing treatment effect differences between the two drugs.*
FDA Label Image

Pradaxa 150mg (5db7f199 8752 4d24 85f7 E34ca8f4d02e 04)

Pradaxa 150mg (5db7f199 8752 4d24 85f7 E34ca8f4d02e 04)
The image shows a packaging label for PRADAXA 150mg capsules, quantity 60. Distributed by Physician Partner, the label lists active ingredient dabigatran etexilate mesylate equivalent to 150mg dabigatran etexilate. It includes lot number, expiration date, and NDC 21695-899-60. Storage instructions specify controlled room temperature of 15°-30°C (59°-86°F). The label features the Physician Partner logo and contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.